AI Takes Center Stage at NEXT New York: Medidata Showcases AI Companions and Orchestrated Intelligence Transforming Life Sciences Industry’s premier life sciences event unveils a new AI ecosystem of companions and Virtual Twins, bridging the virtual and real worlds to orchestrate the entire life sciences lifecycle NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- , a brand and global leader in clinical trial solutions, today unveiled a transformative vision for the life sciences industry at , introducing a suite of AI-based virtual companions engineered to break down silos, accelerate disco...
Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established clinical workflows with AI to power its global oncology pipeline NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a strategic expansion of its partnership with The Menarini Group (“Menarini”), a leading interna...
Medidata and CRIO Empower Over 2,500 Global Research Sites with Seamless Integration to Accelerate Clinical Trials Strategic partnership eliminates human error and provides sponsors with real-time, high-quality clinical data for critical eSource-based trials NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has announced a partnership with , the leading provider of site eSource solutions. The collaboration is driving high data quality standards and efficiencies at over 2,500 research s...
Medidata’s Experience-based AI Earns Top Luminary Rating in Everest Group 2026 Review Rated the highest among 18 providers worldwide, Medidata is the only provider with 100% market adoption score for its end-to-end AI-powered solutions NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has secured the highest “Luminary” rating in . The ranking highlights the industry-leading impact of Medidata’s experience-based AI functionality, which now supports 80% of FDA novel drug approvals in 202...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.